Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
about
Successful use of Rituximab in a patient with recalcitrant multisystemic eosinophilic granulomatosis with polyangiitisImmune mediated diseases and immune modulation in the neurocritical care unitClinical use of biologics in vasculitis syndromes.Interferon-α induced remission in three patients with eosinophilic granulomatosis and polyangiitis. A case study.Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitisRituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).Rituximab: emerging treatment strategies of immune-mediated glomerular disease.Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art.Impact of rituximab trials on the treatment of ANCA-associated vasculitis.Eosinophilic granulomatosis with polyangiitis: an overview.Management of Small Vessel Vasculitides.Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn.Eosinophilic granulomatosis with polyangiitis with severe pulmonary hemorrhage treated with rituximab.Palpable purpura with foot drop: Common presentations in an uncommon disease.EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.The effects of rituximab on serum IgE and BAFF.Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice?Unmet Needs in the Pathogenesis and Treatment of Vasculitides.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis.
P2860
Q35614757-F48B5F37-E7E9-4141-93FE-232F326F1943Q35729575-3B6B3169-3E9F-45D3-BB7C-D8037775F325Q36358081-82AB7AC8-84FD-4D2B-BC55-ABA0A16F3327Q37576518-8F609490-2CAF-4886-A2F2-6A8297337E16Q37640836-A61C5C4A-EA88-4F5A-95D8-54B22C2FC07EQ37690935-2D67512D-C13A-4F95-8229-E6B48AF90415Q38033648-34BD3FAA-D6B2-4B84-B81A-C338828338ABQ38075024-D166AEEC-0893-4182-A296-73221B781949Q38152651-2768F104-54B4-4135-8477-6A6FE900CD06Q38269017-B5512227-0F3A-4664-9814-4223785E0CEFQ38818682-C1957AAB-93BC-497C-81E2-14A2F9566AE9Q38837317-21D06908-C1D6-42AB-B184-DB624DD03955Q39088103-D54B1EAE-D8BB-47CF-A2B1-45AEE9DA63DAQ39088911-368F6AD3-17CF-487D-AC88-297299827747Q40162971-F0D0F33E-FD69-4162-8E7A-B0FC30B60973Q40684657-424A3D57-921C-4F51-ADD5-60A28C802C71Q41208157-52F2ACB3-C747-48D4-8B1D-AF9842E32CD5Q41622904-8A6BB86C-473B-4525-A3A4-0E4BC9D76258Q42426990-B6EC1F81-52C5-4944-89D2-7D1E87054E3BQ42846832-5B13B018-2982-4F57-98F9-DA149D056AEAQ48562190-654A23C8-9FEC-44CF-9CB6-2F1DDCAA1748Q48592090-416BDBF0-54FF-41DC-9989-09827F77628BQ50076914-19840DD0-1ED8-4692-B7B3-BA89836FB8B1Q50903151-5B11636D-C20A-40F6-A770-7D17F204D36D
P2860
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@ast
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@en
type
label
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@ast
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@en
prefLabel
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@ast
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@en
P2093
P2860
P356
P1476
Rituximab for the treatment of Churg-Strauss syndrome with renal involvement.
@en
P2093
Fernando C Fervenza
Karina A Keogh
Rodrigo Cartin-Ceba
Sanjeev Sethi
Ulrich Specks
P2860
P304
P356
10.1093/NDT/GFQ852
P407
P577
2011-02-16T00:00:00Z